Holen Sie sich die Stockscreener-App
1.79
0.00%
0.00
Handel nachbörslich:
1.63
-0.16
-8.94%
Schlusskurs vom Vortag:
$1.79
Offen:
$1.74
24-Stunden-Volumen:
47,763
Relative Volume:
0.16
Marktkapitalisierung:
$1.81M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-26.77M
KGV:
-0.00136
EPS:
-1316.2474
Netto-Cashflow:
$-14.37M
1W Leistung:
+3.47%
1M Leistung:
-52.33%
6M Leistung:
-69.56%
1J Leistung:
+235.08%
1-Tages-Spanne:
$1.73
$1.86
1-Wochen-Bereich:
$1.5232
$1.8893
52-Wochen-Spanne:
$0.0927
$15.90
Glucotrack Inc Stock (GCTK) Company Profile
Firmenname
Glucotrack Inc
Sektor
Telefon
972 (8) 675-7878
Adresse
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
1.79 | 1.81M | 0 | -26.77M | -14.37M | -1,316.25 |
|
ISRG
Intuitive Surgical Inc
|
496.12 | 175.84B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
180.62 | 48.87B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.39 | 39.53B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
259.62 | 38.39B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
45.04 | 37.69B | 27.43B | 1.27B | 1.01B | 1.5829 |
Glucotrack Inc Aktie (GCTK) Neueste Nachrichten
Chart Watch: Will GlucoTrack Inc benefit from geopolitical trendsMarket Risk Summary & Safe Investment Capital Preservation Plans - baoquankhu1.vn
GlucoTrack (NASDAQ:GCTK) and Varex Imaging (NASDAQ:VREX) Financial Survey - Defense World
Earnings Risk: Will GlucoTrack Inc benefit from current market trendsJuly 2025 EndofMonth & Fast Momentum Stock Entry Tips - baoquankhu1.vn
US Market Wrap: Will Voyager Acquisition Corp Equity Warrant benefit from current market trendsPortfolio Gains Summary & AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Why Did Glucotrack Stock Surge 12% Pre-Market Today? - Stocktwits
Glucotrack secures three patents for implantable glucose monitor By Investing.com - Investing.com Nigeria
Glucotrack Announces 3 New Patents to Monitor Blood Glucose - Yahoo Finance
Glucotrack, Inc. (GCTK) stock: slides 30% despite trio of fresh USPTO patents for implantable CBGM platform - parameter.io
GlucoTrack Strengthens IP for Implantable Glucose Monitoring Platform - TipRanks
GlucoTrack’s Share Offering Spurs Market Activity - StocksToTrade
Glucotrack Stumbles Despite Winning Patent - Baystreet.ca
Glucotrack, Inc. Announces USPTO Approval for CBGM Patents - TradingView
Glucotrack secures three patents for implantable glucose monitor - Investing.com
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech - Investing.com Nigeria
Glucotrack stock soars after USPTO approves patents for glucose monitoring tech By Investing.com - Investing.com South Africa
Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform - marketscreener.com
Implantable glucose sensor designed for 3 years, backed by new US patents - stocktitan.net
Published on: 2026-01-29 16:41:28 - baoquankhu1.vn
History Review: Can First BanCorp grow without external fundingJuly 2025 Closing Moves & Safe Entry Momentum Tips - baoquankhu1.vn
Market Review: Can WETH lead its sector in growthJuly 2025 Recap & Accurate Intraday Trade Tips - baoquankhu1.vn
Aug Update: Is Strategic Education Inc likely to announce a buybackJuly 2025 Patterns & Advanced Swing Trade Entry Alerts - baoquankhu1.vn
GlucoTrack (NASDAQ:GCTK) Trading 2.9% Higher – Here’s What Happened - Defense World
Highs Report: Is GlucoTrack Inc impacted by rising ratesInflation Watch & Growth Oriented Trade Recommendations - baoquankhu1.vn
How GlucoTrack Inc. stock performs in rising dollar environmentEarnings Recap Report & Risk Managed Trade Strategies - bollywoodhelpline.com
Risk Analysis: Can GlucoTrack Inc beat the S P 5002025 Market Overview & Weekly High Return Stock Forecasts - baoquankhu1.vn
Will GlucoTrack Inc. stock reach all time highs in 20252025 Trade Ideas & Fast Exit/Entry Strategy Plans - ulpravda.ru
Why GlucoTrack Inc. stock remains undervaluedTrade Risk Summary & AI Powered Buy and Sell Recommendations - Улправда
Is GlucoTrack Inc. stock positioned well for digital economyWeekly Gains Report & Growth Focused Entry Reports - Улправда
Is GlucoTrack Inc. stock supported by strong fundamentalsJuly 2025 Patterns & AI Powered Trade Plan Recommendations - Улправда
Is GlucoTrack Inc. stock supported by innovation pipelineJuly 2025 Summary & AI Powered Market Entry Strategies - ulpravda.ru
ulpravda> 2026> Will GlucoTrack Inc. stock beat EPS estimatesCEO Change & Weekly High Conviction Trade Ideas - Улправда
Risk On: Is GlucoTrack Inc stock overvalued by current metricsJuly 2025 Retail & Community Consensus Stock Picks - moha.gov.vn
Levels Update: Can GlucoTrack Inc stock maintain operating marginsPortfolio Gains Report & Real-Time Market Trend Scan - moha.gov.vn
Glucotrack reports success in first human glucose monitor trial - MSN
GlucoTrack strengthens capital position with new private placement - TipRanks
Glucotrack Signs Multiple Material Agreements - TradingView — Track All Markets
Glucotrack announces pricing of private placement - Medical Buyer
Glucotrack raises $4 million in private placement to fund operations By Investing.com - Investing.com Nigeria
GlucoTrack Issues Investor Presentation Under Regulation FD - The Globe and Mail
Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor - The Globe and Mail
GlucoTrack stock falls after announcing $4 million private placement By Investing.com - Investing.com Australia
GlucoTrack stock falls after announcing $4 million private placement - Investing.com India
Glucotrack raises $4 million in private placement to fund operations - Investing.com
Diabetes tech firm lands $4M backing from single institutional investor - Stock Titan
Can GlucoTrack Inc stock weather global recession2025 Major Catalysts & Precise Swing Trade Entry Alerts - moha.gov.vn
Finanzdaten der Glucotrack Inc-Aktie (GCTK)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.28%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):